BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

InfaCare To Present At Wells Fargo Healthcare Forum


10/19/2005 5:12:49 PM

NEPTUNE, N.J., Feb. 23 /PRNewswire/ -- InfaCare Pharmaceutical Corporation announced today that John R. Post, InfaCare's President and CEO, is scheduled to present at the upcoming Wells Fargo Healthcare Conference on Wednesday, March 2, 2005 at 10:00am. This conference is an opportunity for a broad range of biomedical companies to meet with healthcare-focused institutional investors over several days, from March 1-2, at the St. Regis Hotel in New York City.

For those unable to attend the conference in person, it is also being made available via webcast. The audio portion of InfaCare's presentation will be broadcast live and can be accessed at http://www.wallstreetwebcasting.com/webcast/wfc/infacare.

About InfaCare Pharmaceutical Corporation:

InfaCare is a privately held, specialty pharmaceutical company focused on the neonatal and pediatric markets. The company is currently developing Stanate(R) for the treatment of hyperbilirubinemia, the cause of jaundice and potential neurological damage, in neonates. InfaCare was founded in 2001 by Dr. Robert A. Vukovich, who is also Founder and former CEO of Roberts Pharmaceutical Corporation, and Founder and CEO of WellSpring Pharmaceutical Corporation.

InfaCare Pharmaceutical Corporation

CONTACT: Nancy Bracken, InfaCare Pharmaceutical Corporation,+1-732-938-5885, Fax: +1-732-751-9328



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES